Literature DB >> 7869524

Patterns of metastatic spread in prepubertal yolk sac tumor of the testis.

R W Grady1, J H Ross, R Kay.   

Abstract

Of the 212 patients with yolk sac tumors of the testis registered in the prepubertal testis tumor registry of the American Academy of Pediatrics, Section on Urology, we report on 33 who presented with metastatic disease. Metastases occurred to the retroperitoneum alone in 9 cases, sites consistent with hematogenous spread of disease alone in 13, sites consistent with lymphatic and hematogenous spread in 6, and sites not clearly documented in the registry in 5. These findings, which show a hematogenous predilection in the spread of metastases, suggest that retroperitoneal lymph node dissection has no routine role in the treatment of the child who presents with yolk sac tumor of the testis.

Entities:  

Mesh:

Year:  1995        PMID: 7869524

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Prepubertal testis tumors.

Authors:  Jonathan H Ross; Robert Kay
Journal:  Rev Urol       Date:  2004

Review 2.  [Management of pediatric testicular tumors : diagnosis, therapy, and follow-up].

Authors:  J Steffens; A Treiyer; G Calaminus
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

3.  High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.

Authors:  Hadi Shojaei; Hong Hong; Raymond W Redline
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

4.  Endodermal sinus tumor of testis with acute intestinal obstruction: A rare presentation.

Authors:  Biswanath Mukhopadhyay; Ram M Shukla; Madhumita Mukhopadhyay; Kartik Chandra Mandal; Dipankar Roy
Journal:  J Indian Assoc Pediatr Surg       Date:  2012-01

5.  Risk-adapted treatment reduced chemotherapy exposure for clinical stage I pediatric testicular cancer.

Authors:  Yun-Lin Ye; Zhuang-Fei Chen; Jun Bian; Hai-Tao Liang; Zi-Ke Qin
Journal:  BMC Med Inform Decis Mak       Date:  2020-12-14       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.